Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production

Journal of the National Cancer Institute

Volumn 85, Issue 21, 1993, Pages 1758-1764

  Azzam, Hala S ^a   Arand, Gloria ^b   Lippman, Marc E ^b   Thompson, Erik W ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b Vincent T Lombardi Cancer Research Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRONECTIN; GELATIN; GELATINASE;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL;

BREAST NEOPLASMS; COLLAGEN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GELATINASE A; GELATINASES; HUMAN; METALLOENDOPEPTIDASES; NEOPLASM METASTASIS; PROTEASE INHIBITORS; SENSITIVITY AND SPECIFICITY; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0027451998     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/85.21.1758     Document Type: Article

References (42)

1. Liotta LA, Tryggvason K, Garbisa S, et al: Partial purification and characterization of a neutral protease which cleaves type IV collagen. Biochem 20:100-104, 1981
2. Goldberg GI, Eisen AZ: Extracellular matrix metalloproteinases in tumor invasion and metastasis. In Advances in Cellular and Molecular Biology of Breast Cancer: Regulatory Mechanisms in Breast Cancer (Lippman ME, Dickson RB, eds). Boston: Kluwer Acad Publ, 1990, pp 421-440
3. Stetler-Stevenson WG: Type IV colla- genases in tumor invasion and metastasis. Cancer Metastasis Rev 9:289-303, 1990
4. Liotta LA, Kleinerman J, Catanzaro P, et al: Degradation of basement membrane by murine tumor cells. J Natl Cancer Inst 58:1427-1431, 1977
5. Terranova VP, Hujanen ES, Martin GR: Basement membrane and the invasive activity of metastatic tumor cells. J Natl Cancer Inst 77:311-316, 1986
6. Liotta LA, Tryggvason K, Garbisa S, et al: Metastatic potential correlates with enzytna-tic degradation of basement membrane collagen. Nature 284:67-68, 1980
7. Ura H, Bonfil RD, Reich R, et al: Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res 49:4615-4621, 1989
8. Hendrix MJ, Wood WR, Seftor EA, et al: Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 50:4121-4130, 1990
9. Turpeenniemi-Hujanen T, Thorgeirsson UP, Hart IR, et al: Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. JNCI 75:99-103, 1985
10. Nakajima M, Welch DR, Belloni PN, et al: Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47:4869-4876, 1987
11. Garbisa S, Pozzatti R, Muschel RJ, et al: Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-Ela. Cancer Res 47:1523-1528, 1987
12. Albini A, Melchiori A, Santi L, et al: Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 83:775-779, 1991
13. Hoyhtya M, Hujanen E, Turpeenniemi- Hujanen T, et al: Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase. Int J Cancer 46:282-286, 1990
14. Melchiori A, Albini A, Ray JM, et al: Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. Cancer Res 52:2353-2356, 1992
15. Collier IE, Wilhelm SM, Eisen AZ, et al: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263:6579-6587, 1988
16. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154, 1991
17. Springman EB, Angleton EL, Birkedal- Hansen H, et al: Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys-73 active-site zinc complex in latency and a “cysteine switch” mechanism for activation. Proc Natl Acad Sci USA 87:364368, 1990
18. Steller-Stevenson WG, Krutzsch HC, Wacher MP, et al: The activation of human type IV collagenase proenzyme. J Biol Chem 264:1353-1356, 1989
19. Overall CM, Sodek J: Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the tissue inhibitor of matrix metalloproteinases. J Biol Chem 265:21141-21151, 1990
20. Ward RV, Atkinson SJ, Slocombe PM, et al: Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa pro- gelatinase by fibroblast membranes. Bio- chim Biophys Acta 1079:242-246, 1991
21. Murphy G, Willenbrock F, Ward RV, et al: The C-terminal domain of the 72 kDa gelatinase A is not required for catalysis but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 283:637-641, 1992
22. Brown PD, Levy AT, Margulies IM, et al: Independent expression and cellular processing of Mr 72, 000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50:61846191, 1990
23. Azzam HS, Thompson EW: Collagen- induced activation of the M, 72, 000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res 52:4540-4544, 1992
24. Thompson EW, Paik S, Brtlnner N, et al: Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150:534-544, 1992
25. Bae SN, Arand G, Azzam H, et al: Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in matngel-based in vitro assays. Breast Cancer Res Treat 24:241-255, 1993
26. Kleinman HK, McGarvey ML, Hassell JR, et al: Basement membrane complexes with biological activity. Biochemistry 25:312— 318, 1986
27. Reich R, Thompson EW, Iwamoto Y, et al: Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48:3307-3312, 1988
28. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374-17378, 1989
29. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymenzed substrates. Anal Biochem 102:196-202, 1980
30. Bordier C: Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 256:1604-1607, 1981
31. Chen WT, Hasegawa E, Hasegawa T, et al: Development of cell surface linkage complexes in cultured fibroblasts. J Cell Biol 100:1103-1114, 1985
32. Sommers CL, Walker-Jones D, Heckford SE, et al: Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene- transformed mammary epithelial cells. Cancer Res 49:4258-4263, 1989
33. Zucker S, Moll UM, Lysik RM, et al: Extraction of type-IV collagenase/gelatinase
34. from plasma membranes ot human cancer cells. Int J Cancer 45:1137-1142, 1990 1)
35. r 72, 000 type IV collagenase. Cancer Res 52:5845-5848, 1992
36. D’Errico A, Garbisa S, Liotta LA, et al: Augmentation of type IV collagenase, lami- nin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 4:239-246, 1991
37. Monteagudo C, Merino MJ, San-Juan J, et al: Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 136:585-592, 1990
38. Brown PD, Bloxidge RE, Anderson E, et al: Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 11:183-189, 1993
39. Thompson EW, Yoon J, Burgess MB, et al: Matrix metallo-proteinase family analysis in human breast cancer cell lines of differential in vivo and in vitro invasiveness. Proc Am Assoc Cancer Res 32:71, 1991
40. Vartio T, Baumann M: Human gelatinase type IV procollagenase is a regular plasma component. FEBS Lett 255:285-289, 1989
41. Ohtani H, Kuroiwa A, Obinata M, et al: Identification of type I collagen-producing cells in human gastrointestinal carcinomas by non-radioactive in situ hybridization and immunoelectron microscopy. J Histochem Cytochem 40:1139-1146, 1992
42. Schillaci R, Luparello C, Minafra S: Type I and I-tnmer collagens as substrates for breast carcinoma cells in culture. Effect on growth rate, morphological appearance and actin organization. Eur J Cell Biol 48:135-141, 1989